|
Smith, Wally R; Ballas, Samir K; McCarthy, William F et al. (2011) The association between hydroxyurea treatment and pain intensity, analgesic use, and utilization in ambulatory sickle cell anemia patients. Pain Med 12:697-705
|
|
Ballas, Samir K; Bauserman, Robert L; McCarthy, William F et al. (2010) Hydroxyurea and acute painful crises in sickle cell anemia: effects on hospital length of stay and opioid utilization during hospitalization, outpatient acute care contacts, and at home. J Pain Symptom Manage 40:870-82
|
|
Ballas, Samir K; McCarthy, William F; Guo, Nan et al. (2010) Early detection of response to hydroxyurea therapy in patients with sickle cell anemia. Hemoglobin 34:424-9
|
|
Steinberg, Martin H; McCarthy, William F; Castro, Oswaldo et al. (2010) The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up. Am J Hematol 85:403-8
|
|
Ballas, Samir K; Bauserman, Robert L; McCarthy, William F et al. (2010) The impact of hydroxyurea on career and employment of patients with sickle cell anemia. J Natl Med Assoc 102:993-9
|
|
Smith, Wally R; Bauserman, Robert L; Ballas, Samir K et al. (2009) Climatic and geographic temporal patterns of pain in the Multicenter Study of Hydroxyurea. Pain 146:91-8
|
|
Ballas, Samir K; Barton, Franca B; Waclawiw, Myron A et al. (2006) Hydroxyurea and sickle cell anemia: effect on quality of life. Health Qual Life Outcomes 4:59
|
|
Steinberg, Martin H; Barton, Franca; Castro, Oswaldo et al. (2003) Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA 289:1645-51
|
